Rh(III) and Ru(II) Complexes With Phosphanyl–Alkylamines: Inhibition of DNA Synthesis Induced By Anticancer Rh Complex

References

• Rosenberg B , van CampL , KrigasT. Inhibition of cell division in Escherichia coli by electrolysis products from a platinum electrode. Nature205(4972), 698–699 (1965).
   PubMed Web of Science ®Google Scholar
• Sigel A , SigelH, FreisingerE, SigelRKO. ( Eds). Metallo-Drugs: Development and Action of Anticancer Agents. Metal Ions in Life Sciences Book 18, De Gruyter (Berlin, Germany), 1st ed. (2018).
   Google Scholar
• Štarha P , VančoJ , TrávníčekZ. Platinum iodido complexes: a comprehensive overview of anticancer activity and mechanisms of action. Coord. Chem. Rev.380, 103–135 (2019).
   Web of Science ®Google Scholar
• Gibson D . Platinum(IV) anticancer agents; are we en route to the holy grail or to a dead end?J. Inorg. Biochem.217, 111353 (2021).
   PubMed Web of Science ®Google Scholar
• Deng Z , LiH , ChenSet al. Near-infrared-activated anticancer platinum(IV) complexes directly photooxidize biomolecules in an oxygen-independent manner. Nat. Chem.15, 930–939 (2023).
   PubMed Web of Science ®Google Scholar
• Anthony EJ , BolithoEM , BridgewaterHEet al. Metallodrugs are unique: opportunities and challenges of discovery and development. Chem. Sci.11(48), 12888–12917 (2020).
   PubMed Web of Science ®Google Scholar
• Choroba K , MachuraB , Szlapa-KulaAet al. Square planar Au(III), Pt(II) and Cu(II) complexes with quinoline-substituted 2,2′:6′,2″-terpyridine ligands: from in vitro to in vivo biological properties. Eur. J. Med. Chem.218, 113404 (2021).
   PubMed Web of Science ®Google Scholar
• Elsayed SA , BadrHE , di BiaseA , El-HendawyAM. Synthesis, characterization of ruthenium(II), nickel(II), palladium(II), and platinum(II) triphenylphosphine-based complexes bearing an ONS-donor chelating agent: interaction with biomolecules, antioxidant, in vitro cytotoxic, apoptotic activity and cell cycle analysis. J. Inorg. Biochem.223, 111549 (2021).
   PubMed Web of Science ®Google Scholar
• Patra SA , MohantyM , BanerjeeAet al. Protein binding and cytotoxic activities of monomeric and dimeric oxido-vanadium(V) salan complexes: exploring the solution behavior of monoalkoxido-bound oxido-vanadium(V) complex. J. Inorg. Biochem.224, 111582 (2021).
   PubMed Web of Science ®Google Scholar
• Suárez-Ortiz GA , Hernández-CorreaR , Morales-MorenoMDet al. Diastereomeric separation of chiral fac-tricarbonyl(iminopyridine) rhenium(I) complexes and their cytotoxicity studies: approach toward an action mechanism against glioblastoma. J. Med. Chem.65(13), 9281–9294 (2022).
   PubMed Web of Science ®Google Scholar
• Jaros SW , KomarnickaUK , KyziołAet al. Therapeutic potential of a water-soluble silver-diclofenac coordination polymer on 3D pancreatic cancer spheroids. J. Med. Chem.65(16), 11100–11110 (2022).
   PubMed Web of Science ®Google Scholar
• Gou Y , JiaX , HouLXet al. Dithiocarbazate-FeIII, -CoIII, -NiII, and -ZnII complexes: design, synthesis, structure, and anticancer evaluation. J. Med. Chem.65(9), 6677–6689 (2022).
   PubMed Web of Science ®Google Scholar
• Wang ZF , ZhouXF , WeiQCet al. Novel bifluorescent Zn(II)-cryptolepine-cyclen complexes trigger apoptosis induced by nuclear and mitochondrial DNA damage in cisplatin-resistant lung tumor cells. Eur. J. Med. Chem.238, 114418 (2022).
   PubMed Web of Science ®Google Scholar
• Flocke LS , TrondlR , JakupecMA , KepplerBK. Molecular mode of action of NKP-1339–a clinically investigated ruthenium-based drug–involves ER- and ROS-related effects in colon carcinoma cell lines. Invest. New Drugs34(3), 261–268 (2016).
   PubMed Web of Science ®Google Scholar
• Monro S , ColónKL , YinHet al. Transition metal complexes and photodynamic therapy from a tumor-centered approach: challenges, opportunities, and highlights from the development of TLD1433. Chem. Rev.119(2), 797–828 (2019).
   PubMed Web of Science ®Google Scholar
• Kawczyk-Krupka A , WawrzyniecK , MusiolSK , PotempaM , BugajAM , SierońA. Treatment of localized prostate cancer using WST-09 and WST-11 mediated vascular targeted photodynamic therapy – A review. Photodiag. Photodyn. Ther.12(4), 567–574 (2015).
   PubMed Web of Science ®Google Scholar
• Liu N , LiX , HuangHet al. Clinically used antirheumatic agent auranofin is a proteasomal deubiquitinase inhibitor and inhibits tumor growth. Oncotarget5(14), 5453–5471 (2014).
   PubMedGoogle Scholar
• Lazic S , KasplerP , ShiGet al. Novel osmium-based coordination complexes as photosensitizers for panchromatic photodynamic therapy. Photochem. Photobiol.93(5), 1248–1258 (2017).
   PubMed Web of Science ®Google Scholar
• Zhang P , HuangH , BanerjeeSet al. Nucleus-targeted organoiridium-albumin conjugate for photodynamic cancer therapy. Angew. Chem. Int. Ed.58(8), 2350–2354 (2019).
   PubMed Web of Science ®Google Scholar
• Meier-Menches SM , GernerC , BergerW , HartingerCG , KepplerBK. Structure-activity relationships for ruthenium and osmium anticancer agents-towards clinical development. Chem. Soc. Rev.47(3), 909–928 (2018).
   PubMed Web of Science ®Google Scholar
• Leung CH , ZhongHJ , ChanDSH , MaDL. Bioactive iridium and rhodium complexes as therapeutic agents. Coord. Chem. Rev.257(11-12), 1764–1776 (2013).
   Web of Science ®Google Scholar
• Máliková K , MasarykL , ŠtarhaP. Anticancer half-sandwich rhodium(III) complexes. Inorganics9(4), 26 (2021).
   Web of Science ®Google Scholar
• Štarha P , TrávníčekZ. Non-platinum complexes containing releasable biologically active ligands. Coord. Chem. Rev.395, 130–145 (2019).
   Web of Science ®Google Scholar
• Prathima TS , ChoudhuryB , AhmadMG , ChandaK , BalamuraliMM. Recent developments on other platinum metal complexes as target-specific anticancer therapeutics. Coord. Chem. Rev.490, 215231 (2023).
   Web of Science ®Google Scholar
• Matsheku AC , ChenMYH , JordaanS , PrinceS , SmithGS , MakhubelaBCE. Acridine-containing RuII, OsII, RhIII and IrIII half-sandwich complexes: synthesis, structure and antiproliferative activity. Appl. Organomet. Chem.31(12), e3852 (2017).
   Web of Science ®Google Scholar
• Parveen S , HanifM , LeungEet al. Anticancer organorhodium and -iridium complexes with low toxicity in vivo but high potency in vitro: DNA damage, reactive oxygen species formation, and haemolytic activity. Chem. Commun.55(80), 12016–12019 (2019).
   PubMed Web of Science ®Google Scholar
• Hu X , GuoL , LiuMet al. Increasing anticancer activity with phosphine ligation in zwitterionic half-sandwich iridium(III), rhodium(III), and ruthenium(II) complexes. Inorg. Chem.61(49), 20008–20025 (2022).
   PubMed Web of Science ®Google Scholar
• Nahaei A , MandeganiZ , ChamyaniSet al. Half-sandwich cyclometalated RhIII complexes bearing thiolate ligands: biomolecular interactions and in vitro and in vivo evaluations. Inorg. Chem.61(4), 2039–2056 (2022).
   PubMed Web of Science ®Google Scholar
• Dkhar L , VermaAK , BanothuV , KaminskyW , KolliparaMR. Ruthenium, rhodium, and iridium complexes featuring coumarin hydrazone derivatives: synthesis, characterization, and preliminary investigation of their anticancer and antibacterial activity. Appl. Organomet. Chem.36(4), e6589 (2022).
   Web of Science ®Google Scholar
• Wang ZF , NaiXL , XuYet al. Cell nucleus localization and high anticancer activity of quinoline-benzopyran rhodium(III) metal complexes as therapeutic and fluorescence imaging agents. Dalton Trans.51(34), 12866–12875 (2022).
   PubMed Web of Science ®Google Scholar
• Mészáros JP , KandiollerW , SpenglerGet al. Half-sandwich rhodium complexes with releasable N-donor monodentate ligands: solution chemical properties and the possibility for acidosis activation. Pharmaceutics15(2), 356 (2023).
   PubMed Web of Science ®Google Scholar
• Geldmacher Y , SplithK , KitanovicIet al. Cellular impact and selectivity of half-sandwich organorhodium(III) anticancer complexes and their organoiridium(III) and trichloridorhodium(III) counterparts. J. Biol. Inorg. Chem.17(4), 631–646 (2012).
   PubMed Web of Science ®Google Scholar
• Soldevila-Barreda JJ , HabtemariamA , Romero-CanelónI , SadlerPJ. Half-sandwich rhodium(III) transfer hydrogenation catalysts: reduction of NAD+ and pyruvate, and antiproliferative activity. J. Inorg. Biochem.153, 322–333 (2015).
   PubMed Web of Science ®Google Scholar
• Abdur-Rashid K , GuoR , LoughAJ , MorrisRH , SongD. Synthesis of ruthenium hydride complexes containing beta-aminophosphine ligands derived from amino acids and their use in the H2-hydrogenation of ketones and imines. Adv. Synth. Catal.347(4), 571–579 (2005).
   Web of Science ®Google Scholar
• Blaquiere N , Diallo-GarciaS , GorelskySI , BlackDA , FagnouK. Ruthenium-catalyzed dehydrogenation of ammonia boranes. J. Am. Chem. Soc.130(43), 14034–14035 (2008).
   PubMed Web of Science ®Google Scholar
• Wingad RL , GatesPJ , StreetSTG , WassDF. Catalytic conversion of ethanol to n-butanol using ruthenium P-N ligand complexes. ACS Catal.5(10), 5822–5826 (2015).
   Web of Science ®Google Scholar
• Angoy M , JiménezMV , García-OrduñaP , OroLA , VispeE , Pérez-TorrenteJJ. Dinuclear phosphine-amido [Rh2(diene){μ-NH(CH2)3PPh2}2] complexes as efficient catalyst precursors for phenylacetylene polymerization. Organometallics38(9), 1991–2006 (2019).
   Web of Science ®Google Scholar
• Soldevila-Barreda JJ , SadlerPJ. Approaches to the design of catalytic metallodrugs. Curr. Opin. Chem. Biol.25, 172–183 (2015).
   PubMed Web of Science ®Google Scholar
• Yu Z , CowanJA. Catalytic metallodrugs: substrate-selective metal catalysts as therapeutics. Chem. Eur. J.23(57), 14113–14127 (2017).
   PubMed Web of Science ®Google Scholar
• Bertrand B , BodioE , RichardP , PicquetM , LeGendre P , CasiniA. Gold(I) N-heterocyclic carbene complexes with an “activable” ester moiety: possible biological application. J. Organomet. Chem.775, 124–129 (2015).
   Web of Science ®Google Scholar
• Luengo A , Fernández-MoreiraV , MarzoI , GimenoMC. Trackable metallodrugs combining luminescent Re(I) and bioactive Au(I) fragments. Inorg. Chem.56(24), 15159–15170 (2017).
   PubMed Web of Science ®Google Scholar
• Tasan S , LiconaC , DoulainPEet al. Gold-phosphine-porphyrin as potential metal-based theranostics. J. Biol. Inorg. Chem.20(1), 143–154 (2015).
   PubMed Web of Science ®Google Scholar
• Pliquett J , AmorS , Ponce-VargasMet al. Design of a multifunctionalizable BODIPY platform for the facile elaboration of a large series of gold(I)-based optical theranostics. Dalton Trans.47(32), 11203–11218 (2018).
   PubMed Web of Science ®Google Scholar
• Morris DM , McGeaghM , DePeña D , MerolaJS. Extending the range of pentasubstituted cyclopentadienyl compounds: the synthesis of a series of tetramethyl(alkyl or aryl)cyclopentadienes (Cp*R), their iridium complexes and their catalytic activity for asymmetric transfer hydrogenation. Polyhedron84, 120–135 (2014).
   Web of Science ®Google Scholar
• White C , YatesA , MaitlisPM. (η5-Pentamethylcyclopentadienyl)rhodium and -iridium compounds. Inorg. Synth.29, 228–234 (1992).
   Google Scholar
• Cadenbach T , GemelC , SchmidR , FischerRA. Mechanistic insights into an unprecedented C-C bond activation on a Rh/Ga bimetallic complex: a combined experimental/computational approach. J. Am. Chem. Soc.127(48), 17068–17078 (2005).
   PubMed Web of Science ®Google Scholar
• Bennett MA , HuangTN , MathesonTW , SmithAK. (η6 Hexamethylbenzene)ruthenium complexes. Inorg. Synth.21, 74–78 (1982).
   Web of Science ®Google Scholar
• Tönnemann J , RisseJ , GroteZ , ScopellitiR , SeverinK. Efficient and rapid synthesis of chlorido-bridged half-sandwich complexes of ruthenium, rhodium, and iridium by microwave heating. Eur. J. Inorg. Chem.2013(26), 4558–4562 (2013).
   Web of Science ®Google Scholar
• Štarha P , DvořákZ , TrávníčekZ. Half-sandwich Ir(III) and Rh(III) 2,2′-dipyridylamine complexes: synthesis, characterization and in vitro cytotoxicity against the ovarian carcinoma cells. J. Organomet. Chem.872, 114–122 (2018).
   Web of Science ®Google Scholar
• Sheldrick GM . SHELXT-integrated space-group and crystal-structure determination. Acta Crystallogr.A71(1), 3–8 (2015).
   Google Scholar
• Bourhis LJ , DolomanovOV , GildeaR , HowardJAK , PuschmannH. The anatomy of a comprehensive constrained, restrained refinement program for the modern computing environment Olex2 dissected. Acta Crystallogr.A71(1), 59–75 (2015).
   Google Scholar
• Dolomanov O , BourhisLJ , GildeaR , HowardJAK , PuschmannH. OLEX2: a complete structure solution, refinement and analysis program. J. Appl. Crystallogr.42(2), 339–341 (2009).
   Web of Science ®Google Scholar
• Rigaku Oxford Diffraction (2020) CrysAlisPro 1.171.40.82a. (Accessed 12September2020). www.rigaku.com/
   Google Scholar
• Macrae CF , SovagoI , CottrellSJet al. Mercury 4.0: from visualization to analysis, design and prediction. J. Appl. Crystallogr.53(1), 226–235 (2020).
   PubMedGoogle Scholar
• Stoppioni P , DiVaira M , MaitlisPM. Pentamethylcyclopentadienylrhodium complexes with tripod tetradentate ligands and bidentate ‘mixed’ ligands. J. Chem. Soc. Dalton Trans. (6), 1147–1154 (1982).
   Google Scholar
• Groom CR , BrunoIJ , LightfootMP , WardSC. The Cambridge Structural Database. Acta Cryst.B72(2), 171–179 (2016).
   Google Scholar
• The European Collection of Authenticated Cell Cultures. (Accessed 15May2023). www.culturecollections.org.uk/products/celllines/generalcell/detail.jsp?refId=93112519&collection=ecacc_gc
   Google Scholar
• Jendželovský R , JendželovskáZ , HiľovskáL , KovaľJ , MikešJ , FedoročkoP. Proadifen sensitizes resistant ovarian adenocarcinoma cells to cisplatin. Toxicol. Letters243, 56–66 (2016).
   PubMed Web of Science ®Google Scholar
• Zhang WY , BridgewaterHE , BanerjeeSet al. Ligand-controlled reactivity and cytotoxicity of cyclometalated rhodium(III) complexes. Eur. J. Inorg. Chem.2020(11-12), 1052–1060 (2020).
   PubMed Web of Science ®Google Scholar
• Soldevila-Barreda JJ , FawibeKB , AzmanovaMet al. Synthesis, characterisation and in vitro anticancer activity of catalytically active indole-based half-sandwich complexes. Molecules25(19), 4540 (2020).
   PubMed Web of Science ®Google Scholar
• Nongpiur CGL , VermaAK , SinghRKet al. Half-sandwich ruthenium(II), rhodium(III) and iridium(III) fluorescent metal complexes containing pyrazoline based ligands: DNA binding, cytotoxicity and antibacterial activities. J. Inorg. Biochem.238, 112059 (2023).
   PubMed Web of Science ®Google Scholar
• Bugarcic T , NovakovaO , HalamikovaAet al. Cytotoxicity, cellular uptake, and DNA interactions of new monodentate ruthenium(II) complexes containing terphenyl arenes. J. Med. Chem.51(17), 5310–5319 (2008).
   PubMed Web of Science ®Google Scholar
• Mühlgassner G , BartelC , SchmidWF , JakupecMA , ArionVB , KepplerBK. Biological activity of ruthenium and osmium arene complexes with modified paullones in human cancer cells. J. Inorg. Biochem.116, 180–187 (2012).
   PubMed Web of Science ®Google Scholar
• Vock CA , AngWH , ScolaroCet al. Development of ruthenium antitumor drugs that overcome multidrug resistance mechanisms. J. Med. Chem.50(9), 2166–2175 (2007).
   PubMed Web of Science ®Google Scholar
• Hayward RL , SchornagelQC , TenteRet al. Investigation of the role of Bax, p21/Waf1 and p53 as determinants of cellular responses in HCT116 colorectal cancer cells exposed to the novel cytotoxic ruthenium(II) organometallic agent, RM175. Cancer Chemother. Pharmacol.55(6), 577–583 (2005).
   PubMed Web of Science ®Google Scholar
• Chatterjee S , KunduS , BhattacharyyaA , HartingerCG , DysonPJ. The ruthenium(II)-arene compound RAPTA-C induces apoptosis in EAC cells through mitochondrial and p53-JNK pathways. J. Biol. Inorg. Chem.13(7), 1149–1155 (2008).
   PubMed Web of Science ®Google Scholar
• Kisova A , ZerzankovaL , HabtemariamA , SadlerPJ , BrabecV , KasparkovaJ. Differences in the cellular response and signaling pathways between cisplatin and monodentate organometallic Ru(II) antitumor complexes containing a terphenyl ligand. Mol. Pharm.8(3), 949–957 (2011).
   PubMedGoogle Scholar
• Hearn JM , Romero-CanelónI , MunroAFet al. Potent organo-osmium compound shifts metabolism in epithelial ovarian cancer cells. PNAS112(29), E3800–E3805 (2015).
   PubMed Web of Science ®Google Scholar
• Soldevila-Barreda JJ , Romero-CanelónI , HabtemariamA , SadlerPJ. Transfer hydrogenation catalysis in cells as a new approach to anticancer drug design. Nat. Commun.6, 6582 (2015).
   PubMed Web of Science ®Google Scholar
• Masaryk L , OrvošJ , SłoczyńskaKet al. Anticancer half-sandwich Ir(III) complex and its interaction with various biomolecules and their mixtures–a case study with ascorbic acid. Inorg. Chem. Front.9(15), 3758–3770 (2022).
   Web of Science ®Google Scholar